• Methylation Profiling
• Biomarker & Diagnostic Development
• Real-Time Methylation Specific PCR
• Epigenetically-Effective Drugs

Distinguished Faculty

• Shilpa Kadam, Ph.D., Novartis Institutes for BioMedical Research, Inc.

• Matthew Guenther, Ph.D., MIT, Whitehead Institute for Biomedical Research

• Robert Brown, Ph.D., University of Glasgow, Cancer Research UK Beatson Laboratories

• Kenneth P. Nephew, Ph.D., Indiana University School of Medicine

• Tomasz K. Wojdacz, M.Sc., Institute of Human Genetics, University of Aarhus, Denmark

• Shuji Ogino, M.D., Ph.D., Dana-Farber Cancer Institute

• David S. Schrump, M.D., National Cancer Institute, NIH

• Yuriko Mori, M.D., Ph.D., Johns Hopkins University

• Donald F. Corcoran, MBA, MethylGene Inc.

• Victor E. Marquez, Ph.D., National Cancer Institute-Frederick, National Institutes of Health

• Andrew Allen, M.D., MRCP, Ph.D., Pharmion Corporation

• Victoria Richon, Ph.D., Merck Research Laboratories

• Wenlin Shao, Ph.D., Novartis Institutes for BioMedical Research

• Giulio F. Draetta, M.D., Merck Research Laboratories